S
Sylvette Hoffstetter
Publications - 54
Citations - 2140
Sylvette Hoffstetter is an academic researcher. The author has contributed to research in topics: Brachytherapy & Epidermoid carcinoma. The author has an hindex of 28, co-authored 54 publications receiving 2072 citations.
Papers
More filters
Journal Article
Pre-operative, post-operative and exclusive irradiation of endometrial adenocarcinoma.
M. Pernot,Sylvette Hoffstetter,Didier Peiffert,F. Guillemin,J. M. Carolus,J. L. Verhaeghe,Elisabeth Luporsi,V. Beckendorf +7 more
TL;DR: A pre- and post-operative radiotherapy results in a reduction of the vaginal relapse rate and the LDR afterloading technique with primary radiotherapy of endometrial adenocarcinoma leads to a locoregional control slightly interior.
Journal ArticleDOI
Influence of dose point and inverse optimization on interstitial cervical and oropharyngeal carcinoma brachytherapy
Faten Ahmad,Pierre Aletti,Claire Charra-Brunaud,Rob van der Laarse,Michel Lapeyre,Sylvette Hoffstetter,Didier Peiffert,Alain Noel +7 more
TL;DR: CT-based optimized implant allows conformation of the dose distribution to the PTV while sparing normal tissue and organs at risk, and an under- or overdose inside the P TV.
Journal ArticleDOI
IR 192 brachytherapy in the management of 147 T2NO oral tongue carcinoma treated with irradiation alone
Journal ArticleDOI
Évaluation de l'importance d'un curage ganglionnaire systématique dans les carcinomes de la cavité buccale traités par curiethérapie seule pour la lésion primaire (À propos d'une série de 346 patients)
TL;DR: Les recidives ganglionnaires sont plus frequentes chez les patients sans curage que chez ceux avec curage pour les T1, T2, N0, mais cela n'est significatif que pour les CLR, the SS and the SG entre les patients a ganglions negatifs au curage and ceuxA gang lions positifs.
Journal ArticleDOI
Late effects of post-high-dose-rate brachytherapy for oropharyngeal carcinoma: are they severer than post-low-dose-rate?
Takayuki Nose,Didier Peiffert,Michel Lapeyre,Sylvette Hoffstetter,Masahiko Koizumi,Kinji Nishiyama +5 more
TL;DR: HDR oropharyngeal brachytherapy is as safe as LDR, and late effects by HDR were not severer than by LDR.